FDA and EMA guidance now call for endpoints that capture the full picture of patient well-being, including physical, psychological, and social. If your obesity trials aren't incorporating this multidimensional approach, ...
Preparing for ICH GCP E6(R3) implementation
A guide to assessing the impact, risk and requirements of the change
Read the whitepaperMeeting requirements for Joint Clinical Assessments
A planning guide for health technology developers
Read the whitepaper
Featured solutions
Blended solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Outcome Measures
A multi-faceted approach to identifying, selecting, and implementing evidence-based measures that matter to patients.
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
Cardiac Safety Solutions
End-to-end cardiac safety solutions, including ECG, event monitoring, BPM, long-term Holter monitoring, ECHO and MUGA studies.
Early Clinical and Bioanalytical Solutions
Innovative early clinical solutions that will advance your drug development strategy.
Site & Patient Solutions
Transforming recruitment through patient-centric trials and real-world, real-time data.
Market Access
Expertise in mission-critical pricing, market access, and reimbursement.
Specialty Laboratory Solutions
Supporting precision medicine programs across all phases of drug diagnostic co-development.
Videos
ICON overview
ICON is expanding the possibilities of clinical research for customers, partners, and patients.
Biotech
Developing transformative therapies with small & mid-sized biopharma companies requires a flexible approach.
Technology solutions
ICON’s technology solutions are focused on the factors most critical to our customers.
AI @ICON
ICON is harnessing AI with pragmatic, impactful, award winning solutions for a healthier world.
Obesity
ICON has the cross functional expertise to help sponsors overcome the challenges associated with obesity research.
Webinars
Strategic approaches for early clinical trials in neurodegenerative diseases
18 November 2025. Register now.
Riding the data wave: How pharma can navigate disruptions in open claims
8 December 2025. Register now.
Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases
Watch the webinar.
